Dr. Mattias Bernow is the CEO of Cellcolabs, a Swedish biotech startup specializing in the industrial production of high-quality stem cells, making them widely available at scale. He holds a medical degree from the Karolinska Institute and a Master of Science from the Stockholm School of Economics. 

Mattias has experience working as a physician at Karolinska Hospital and as a management consultant at Boston Consulting Group (BCG). Before joining Cellcolabs, he co-founded Doctrine, a platform designed to help healthcare providers digitize the patient journey for a more integrated healthcare system.